Mental Health Clinics in Semora, NC Accepting Medicare
1 Mental Health Clinics found. Showing 1 - 1
 Enhancement Health Care # 2 Clinic - Adult Mental Health Medicare: Not Enrolled in Medicare Practice Location: 2407 Ephesus Church Rd, Semora, NC 27343 Phone: 919-479-6600 Fax: 919-479-1010 |
News Archive
Celgene acquires Abraxis BioScience
Celgene Corporation today announced it has completed its acquisition of Abraxis BioScience, Inc. For each share of Abraxis common stock, Abraxis shareholders will receive (i) $58.00 in cash (ii) 0.2617 shares of Celgene common stock, and (iii) one tradeable Contingent Value Right (CVR), which entitles its holder to receive a pro rata share of potential payments for future regulatory milestones and commercial royalties.
Rice bran supplement for infants provides more nutrients, reduces diarrhea
Malnutrition is prevalent on a global scale and has numerous negative consequences for children during the first five years of life. For some children, it can mean struggling with health issues for life or a higher risk of death among those under five years of age.
Compound responsible for chilis' heat may help kill prostate cancer cells
Capsaicin, the compound responsible for chilis' heat, is used in creams sold to relieve pain, and recent research shows that in high doses, it kills prostate cancer cells. Now researchers are finding clues that help explain how the substance works. Their conclusions suggest that one day it could come in a new, therapeutic form.
'Confluence of circumstances' resulted in Haitian cholera outbreak, U.N.-appointed panel says
Haiti's cholera outbreak, which started last October, "was caused by a South Asian strain that contaminated a river where tens of thousands of people wash, bath, drink and play," a report from an independent U.N.-appointed panel said on Wednesday, the Associated Press reports.
Cellix Bio announces completion of Pre-IND meeting with FDA on novel prodrug of mesalamine for ulcerative colitis
Cellix Biosciences Inc., a development-stage pharmaceutical company, today announced successful completion of a Pre-Investigational New Drug meeting with the U.S. Food and Drug Administration for the development of CLX-103, a novel molecular conjugate of mesalamine for the treatment of mild to moderate ulcerative colitis.
› Verified 4 days ago